View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
DOD/DODOASHA | RIN: 0720-AB23 | Publication ID: Fall 2011 |
Title: TRICARE; Off-Label Uses of Devices; Partial List of Examples of Unproven Drugs, Devices, and Medical Treatments or Procedures | |
Abstract: This rule revises the definition of "unlabeled or off-label drug" to "off-label use of a drug or device." This revision is consistent with the regulatory framework under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq). Additionally, this rule removes the partial list of examples of unproven drugs, devices, and medical treatments or procedures proscribed under section 199.4(g)(15). As it is determined that reliable evidence demonstrates that previously unproven drugs, devices, and medical treatments or procedures have proven medical effectiveness, TRICARE has removed them from the list and authorized medically necessary care. This removal of the partial list is necessary as the list will never be completely current and is only a partial list of examples. The removal of this partial list does not change or eliminate any benefits that are currently available under the TRICARE program. | |
Agency: Department of Defense(DOD) | Priority: Substantive, Nonsignificant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Final Rule Stage |
Major: No | Unfunded Mandates: No |
CFR Citation: 32 CFR 199 | |
Legal Authority: 5 USC 301 10 USC ch 55 |
Legal Deadline:
None |
||||||||||||||||||
Timetable:
|
Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
Federalism: No | |
Included in the Regulatory Plan: No | |
RIN Data Printed in the FR: No | |
Related RINs: Previously reported as 0720-AA88 | |
Agency Contact: Rene Morrell Department of Defense Office of Assistant Secretary for Health Affairs 1200 Defense Pentagon, Washington, DC 20301 Phone:303 676-3618 |